CEOCFO Magazine, a “weekly publication featuring in-depth interviews with many of today’s top corporate executives,” recently published an interview with Paul Owen, CEO of OneOme.

In the interview Paul discusses the OneOme RightMed® pharmacogenomic test, an analysis of individual patients’ genetic information to help providers make better prescription decisions. Owen provides insight into the benefits of the test, the science behind the test, and the past and future of OneOme’s success.